Simplex Trading
DFTX

Simplex Trading’s Definium Therapeutics DFTX Stock Holding History

Simplex Trading’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83M Buy
102,700
+33,600
+49% +$830K ﹤0.01% 1233
2026
Q1 		$1.31M Sell
69,100
-39,900
-37% -$677K ﹤0.01% 2220
2025
Q4 		$1.46M Buy
109,000
+10,200
+10% +$126K ﹤0.01% 2245
2025
Q3 		$1.16M Buy
98,800
+26,500
+37% +$247K ﹤0.01% 2903
2025
Q2 		$469K Buy
72,300
+5,800
+9% +$38.1K ﹤0.01% 3573
2025
Q1 		$389K Sell
66,500
-2,300
-3% -$16.5K ﹤0.01% 3662
2024
Q4 		$478K Buy
68,800
+34,700
+102% +$239K ﹤0.01% 3588
2024
Q3 		$194K Buy
34,100
+6,200
+22% +$43.1K ﹤0.01% 4543
2024
Q2 		$201K Sell
27,900
-19,600
-41% -$171K ﹤0.01% 4646
2024
Q1 		$446K Buy
47,500
+28,400
+149% +$162K ﹤0.01% 3960
2023
Q4 		$61K Buy
19,100
+6,600
+53% +$19.9K ﹤0.01% 5902
2023
Q3 		$39K Sell
12,500
-500
-4% -$2.06K ﹤0.01% 6029
2023
Q2 		$46K Buy
13,000
+5,300
+69% +$18.3K ﹤0.01% 5927
2023
Q1 		$24K Sell
7,700
-365,600
-98% -$1.22M ﹤0.01% 6728
2022
Q4 		$821K Sell
373,300
-287,300
-43% -$798K ﹤0.01% 2669
2022
Q3 		$2.31M Buy
660,600
+651,080
+6,839% +$6.25M ﹤0.01% 1830
2022
Q2 		$91K Buy
9,520
+2,513
+36% +$31.8K ﹤0.01% 5692
2022
Q1 		$116K Sell
7,007
-6,966
-50% -$121K ﹤0.01% 5939
2021
Q4 		$289K Sell
13,973
-15,247
-52% -$487K ﹤0.01% 4626
2021
Q3 		$1.5M Buy
29,220
+27
+0.1% +$1.17K ﹤0.01% 2533
2021
Q2 		$1.51M Buy
+29,193
New +$1.53M ﹤0.01% 2552

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Simplex Trading's DFTX Position: Q2 2026 in Review

Simplex Trading increased its Definium Therapeutics (DFTX) stake by 16% in Q2 2026, buying an estimated $160K and bringing the position to 47,651 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

Simplex Trading first reported a position in DFTX in Q2 2021 and has held it in 17 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Simplex Trading held 47,651 shares of Definium Therapeutics worth $2.24M as of Q2 2026.
  • Simplex Trading bought 6,495 Definium Therapeutics shares in Q2 2026, an estimated $160K.
  • Definium Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1922 holding.
  • Simplex Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.